|
⚲
|
| Keyboard |
| DiRaimondo Thomas
✚
|
|
|---|---|
| CIK # | 0002005618 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002005618] | |
| 4 | [0002005618] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Janux Therapeutics Inc | |
| DiRaimondo Thomas |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Janux Therapeutics Inc JANX
Stock option (right to buy) · derivative
|
2026-01-02 | Grant | 109,900 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2026-01-02 | Sell | 2,505 | $13.73 | 34,394 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2026-01-02 | Grant | 31,400 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock option (right to buy) · derivative
|
2025-01-02 | Grant | 84,000 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2025-01-02 | Grant | 24,000 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-09-27 | Sell | 675 | $47.22 | 31,874 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-09-27 | Sell | 4,325 | $46.21 | 199,858 |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 147,000 | $0.00 |